Article
Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis.
International journal of technology assessment in health care - 1 Jan 2002
Chikhaoui Yamina, Gélinas Huguette, Joseph Lawrence, Lance Jean-Marie
Abstract excerpt
OBJECTIVE: Familial adenomatous polyposis (FAP) is a well-known hereditary colorectal cancer-predisposing syndrome. Genetic testing for colorectal cancer risk is now part of standard medical practice, but very little is known about the economic impact of this technology. The aim of this study was to assess, from a healthcare system perspective, the direct costs of two strategies for screening at-risk relatives of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
